miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma

被引:0
作者
Nanmu Yang
Jinxue Zhou
Qingjun Li
Feng Han
Zujiang Yu
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Infectious Disease
[2] Henan Cancer Hospital,Department of Hepatopancreatobiliary Surgery
[3] The Affiliated Tumor Hospital of Zhengzhou University,Department of Hepatopancreatobiliary Surgery
来源
Cancer Cell International | / 19卷
关键词
miR-96; FOXO1; HepG2 cells; AKT/GSK-3β/β-catenin; Proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 40 条
[1]  
Zhang C(2017)Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma Clin Transl Oncol 19 1507-1517
[2]  
Zhuang L(2017)MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma Cell Death Dis 8 e2804-32
[3]  
Best J(2017)Novel implications in the treatment of hepatocellular carcinoma Ann Gastroenterol 30 23-6
[4]  
Song HM(2015)MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells Int J Clin Exp Pathol 8 9889-1450
[5]  
Lian R(2016)MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway Eur J Pharmacol 792 1-4556
[6]  
Ress AL(2015)MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients Mol Carcinog 54 1442-9086
[7]  
Yao Q(2018)microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN Life Sci 203 1-375
[8]  
Bao YH(2017)MiR-96 expression in prostate cancer and its effect on the target gene regulation Eur Rev Med Pharmacol Sci 21 4548-18468
[9]  
Fei X(2018)miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells Oncol Lett 15 9081-821
[10]  
Wang TH(2016)OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma Mol Carcinog 55 366-156